- Genomics Medicine Ireland collaborating with St. Vincent’s University Hospital and University College Dublin to investigate one of Ireland’s most common ailments
- Study aims to lead to more accurate diagnoses and more personalised treatments for patients
Irish life sciences company Genomics Medicine Ireland Ltd (GMI) today announced the launch of a landmark and nationwide study to examine the genomic basis of chronic respiratory conditions, such as asthma, and Asthma-COPD Overlap (ACO), in collaboration with St. Vincent’s University Hospital and University College Dublin (UCD).
GMI collaborating with UHL in first-of-a-kind study into two chronic rheumatic conditions:
Ankylosing Spondylitis & Non-Radiographic Axial Spondyloarthritis Read More
No shying away from red lipstick for these GMI-ers who are pulling out all the stops to raise awareness for World MS Day 2018 on behalf of Multiple Sclerosis Ireland. #kissgoodbyetoms #bringinguscloser #WMSD2018.
We’re delighted to have already reached 1000 participants at our GenoFit research study site at the UCD Institute for Sport & Health. GMI and our UCD collaborators are very grateful to everyone who has volunteered for our study in the few short months since we opened up the UCD clinic. Important research like this wouldn’t be possible without the generosity of the public. More info at www.genofit.ie
Coverage on RTE of the recent GMI and Temple Street Children’s University Hospital discovery which helped saved this young girl’s life.